My boss just offered to stake me $500k

Dude, I just posted a few minutes ago because I'm looking for a financial backer for my trading strategy. I've returned over a 100% in 4 months on my paper trades.

Buy a bunch of SB Credits?

Get a CFP!

No, give it to me. I had a 900% return over 6 months on Bodog....4 game NBA teasers baby. Until i lost it all betting Monte Ellis would go over points+ assists 32 when i was wasted...

But lose....

$500K is a ridiculous amount to work with. Big enough that it's kinda a big deal, too small to really accomplish a huge project with.

I have a couple ideas on the algorithmic trading front as well as a few ideas to help with the sales process in IBD. If you work at the same bank as me, maybe I can help. Otherwise, I have an IPA that I can't violate.

^^^Haha yeah I was about to say.

What is your annualized volatility? 200%? lol

500k into shorting oil when Egypt is done fucking around

Invest it in my fund.

Josh???

Why would you post this on WSO?

So you want me to throw that 500k to you for someone elses idea???

^^^^HAHAHAHAHAHA

well played, sir.

(No way the OP's boss goes on WSO, lol)

Prestige Worldwide

A once in a lifetime business opportunity. The first word in entertainment. Management, financial portfolios, insurance. Security, computers, black leather gloves. Research and development: putting in the man hours to study the science of what you need...last week we put liquid paper on a bee...and it died. Security!

Investors? POSSIBLY YOU!!!?!!!

hahaha ^^^

I would go with coal companies, It is hard to substitute, is in short supply because of the weather and once steel mills get it on again its going to do even better. An M&A deal, but this is kind of risky proposition, is to go into emerging markets. There is a database of a Latam country with reputable financial information about a lot of companies based there, so all you have to do is search which sector do you want, see if any of the companies look good, and then decide (I have used it for credit risk assessments).

YOUR A MORON JOSH

hahaha.

so Paul.Allen was actually his boss?

Wow. This is why we need to have discreet usernames.

Epic fail of the week in the IB world version of break.com

eww.. awkward..

^ ^ ^ ^ LMAO. XD

Rofl, that was awesome

Orexigen (OREX) and I'll explain why later, gotta go eat dinner.

Well A. is the obvious metrics: position of price relative to historic, value, etc etc

B. the cardiac study. The cardiac study is requested because of the effects of bupropion, and it seems like really bad news but it really isn't. First of all bupropion is already approved and is sold as Wellbutrin and Zyban. Granted, Wellbutrin it is not recommended to patients with heart problems, but NOT because it is highly dangerous - it is being compared to SSRIs, which have been shown to have a positive effect on heart health after a heart attack, can't beat that. Also, while depression is loosely linked to heart disease, the link isn't strong enough to offset the potential risk from Wellbutrin. Second, the study would not need to be very long. For obese people, losing even 5-10% of their body weight drastically improves their health and lowers the risk of cardiovascular disease, thus offsetting the risk of cardiac problems that may be caused by elevated blood pressure and increased heart rate that bupropion causes in about 1% of cases. Pretty much the study would need to consist of a more representative profile of obese people, last about 1-2 years (at 5% body weight loss per year), and hopefully avoid deaths. Third, even if the experiment fails for people with heart problems, it doesn't mean that the drug won't be approved. It will just be approved with disclaimers to exclude people with heart disease. Obviously it's not the best scenario, but it's not as bad as not being able to release the drug, which I don't think is a big risk. Another obesity medication that is subject to heart disease restriction is phentermine. It's an amphetamine-based (=heart risks through the roof) appetite suppressant, that is prescribed for short term treatment (no longer than 3 months) ONLY to obese patients without existing heart problems (so similar profile to the subject of the existing Contrave study). Moreover, Zyban also has a disclaimer excluding people with heart problems, and it can be argued that the link between smoking and heart disease is as significant as the risk between obesity and heart disease, and so excluding smokers with heart disease makes the drug useless to people that need it the most (argument used to justify speculation why a cardiac study not showing benefit to obese people with heart disease would not get the drug approved)

Of course, there's a risk that OREX will chose to not bother (although I don't see why they wouldn't, since FDA will most like request similar cardio data for their other bupropione based drug), but there's another ace in the sleeve:

C. Empatic While Empatic is still in stage 2, I believe that it will be much more promising than Contrave, mainly because I like Zonisamide better than naltrexone. First of all, bupropione's main side effect is not heart problems, it is seizures. Seizures are very dose-dependent, so the higher the dose, the higher is the risk of seizures. By combining bupropione with a seizure medication such as zonisamide, the dosage of bupropione can be increased significantly without increasing incidence of seisures. At higher doses bupropione would be more effective for weight loss, and at that point the risk/reward profile of the drug changes significantly and the heart risk wouldn't be as big of a problem. Second, as a GABA reuptake inhibitor, it would foster better self-control. And let's be realistic here - fat people aren't fat because they have special hoarding genes (theory has been refuted) or a super low metabolism , but because they have no self-control around food. Third, loss of appetite is one of the side effects. And last but not least, FDA issued a warning that it may cause metabolic acidosis. Sounds horrible, right? Except that metabolic acidosis in this case is most likely ketoacidosis (eliminating other causes such as renal failure which would be excluded as a pre-existing condition), and ketoacidosis is an out of control ketosis. So if some people have an out of control ketosis, i think it is a prudent assumption that many others get normal ketosis, and while an actual study would need to be done, i think in this case the indication may be that zonisamide encourages the body to enter a ketotic state, i.e. use fat reserves for fuel, rather than crave glucose . Because of these characteristics of zonisamide, I believe that the results of stage 3 of Empatic will be very very promising.

P.S: A lot of my points are addressing the concerns in the anti-orex articles, such as this for example:

http://seekingalpha.com/article/250322-orexigen-therapeutics-70-off-is-…

PM me got a decent idea to bump out nice cash flow with that kind of money

lol. No way my boss is on here. He doesn't spend time surfing.

Wallstreetballa, you got pm.

buy some puts on high end clothing stores